Skip to main content
FinSpry Logo
FinSpry
OTLK logo
OTLK
(NASDAQ)
Outlook Therapeutics, Inc.
$0.23-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Outlook Therapeutics (OTLK) Stock Price & Financial Analysis

Outlook Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.22 - $0.23
52-Week High$3.39
52-Week Low$0.16
Open$0.23
Volume2.63M
Average Volume (3M)4.99M
Market Cap13.73M
Shares Outstanding60.20M
Price to Sales (P/S)66.76
Price to Book (P/B)-0.36
EV/EBITDA-0.69
Revenue (TTM)205.70K
Net Income (TTM)-102.86M
Free Cash Flow (TTM)-14.94T
EPS (TTM)$-2.35
Profit Margin-50004.67%
Operating Margin-28652.50%
50-Day MA$0.29
200-Day MA$1.05
52-Week Change-84.42%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Outlook Therapeutics

What is the current stock price for OTLK?

As of the latest trading session, OTLK stock trades at $0.23. The 52-week range is $0.16–$3.39, with a day range of $0.22–$0.23.

What is the P/E ratio for OTLK?

The P/E ratio (Price-to-Earnings) for OTLK is shown in the Key Statistics section. This valuation metric helps compare Outlook Therapeutics, Inc. to industry peers.

Does OTLK pay dividends?

Outlook Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OTLK?

Based on 3 analysts, the consensus for OTLK is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OTLK?

Outlook Therapeutics's market capitalization is $13.8M, classifying it as a micro-cap company. Outlook Therapeutics operates in the Healthcare sector within the Biotechnology industry.